A detailed history of Sivia Capital Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 3,572 shares of ABT stock, worth $419,209. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,572
Previous 3,443 3.75%
Holding current value
$419,209
Previous $358 Million 13.83%
% of portfolio
0.24%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$100.07 - $118.13 $12,909 - $15,238
129 Added 3.75%
3,572 $407 Million
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $40,493 - $45,200
402 Added 13.22%
3,443 $358 Million
Q1 2024

Apr 18, 2024

SELL
$109.52 - $120.96 $1,314 - $1,451
-12 Reduced 0.39%
3,041 $346 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $275,350 - $337,051
3,053 New
3,053 $336 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sivia Capital Partners, LLC Portfolio

Follow Sivia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivia Capital Partners, LLC with notifications on news.